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background:  Atrial fibrillation (AF) is the most common cardiac complication of hyperthyroidism. The association between hyperthyroidism and 
stroke remains unclear. Our aims were to determine if thyroid dysfunction and especially hyperthyroidism was a thromboembolic risk factor among 
AF patients with contemporary management.
methods:  Patients with AF seen in an academic institution between 2000 and 2010 were identified in a database and followed up. All stroke 
or hromboembolism, bleeding events and death were recorded and related to thyroid status and disorders. Associations were examined in time-
dependent Cox models with adjustment for relevant confounders.
results:  Among 8962 patients, 141 patients had a history of hyperthyroidism, 540 had a history of hypothyroidism and 8271 had no 
thyroid dysfunction. Amiodarone-induced dysfunction thyroid was found in 42 (30%) patients with hyperthyroidism and 76 (14%) patients with 
hypothyroidism. The average CHA2DS2-VASc score was 3.1±1.8 for the no thyroid dysfunction group, 3.1±1.8 for the hyperthyroidism group, and 
4.0±1.7 for the hypothyroidism group. Mean follow-up was 929±1082 days and there were 715 strokes or systemic thromboembolism. There was 
no significant difference regarding the rate of stroke in patients with thyroid dysfunction neither in univariate nor in multivariate analysis (including 
adjustment on anticoagulation use) compared to patients without thyroid problems: HR=0.85 (95%CI 0.41-1.76) for history of hypothyroidism, 
HR=0.98 (95%CI 0.73-1.34) for history of hyperthyroidism. There were 791 bleeding events and hypothyroidism was independently related to a 
higher rate of bleeding events (HR=1.35, 95%CI 1.02-1.79). No significant difference regarding the incidence of death rate was observed in the 3 
groups.
conclusion:  Thyroid dysfunction and especially hyperthyroidism was not a risk factor for stroke an thromboembolism. Furthermore, hypothyroidism 
was associated with a higher risk of bleeding events. The CHA2DS2VASC score should be the main parameter to determine the best anticoagulation 
strategy in AF patients with thyrotoxicosis.
